KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Peak Chain / Genetix Chain: 25 Kovera certificates.
The lab's record shows 25 certificates printed for Peak Chain / Genetix Chain, analysed between 29 Mar 2026 and 20 Apr 2026, covering 23 products. Median HPLC purity is 99.96%. Kovera graded 25 as a pass and 0 as a fail.
25
certificates
99.96%
median purity
23
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 25 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 14 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
23 AS PRINTEDRetatrutide · 35-Amino-1MQ · 1AOD-9604 · 1ARA-290 · 1BPC-157 · 1CJC-1295 no DAC · 1DSIP · 1Epithalon · 1GHK-Cu · 1Glutathione · 1Ipamorelin · 1Kisspeptin-10 · 1KPV · 1LL-37 · 1MOTS-c · 1NAD+ · 1PT-141 · 1Selank · 1Semax · 1SLU-PP-332 · 1SS-31 · 1TB-500 (Thymosin B4) · 1Thymosin alpha-1 · 1
Every certificate
NEWEST FIRST · 25 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-C99ED6 | Retatrutide | 1111-0960 | 99.977% | 118.0%11.8 of 10 mg | 20 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AFEEC6 | Retatrutide | 1111+0953 | 99.809% | 108.0%21.59 of 20 mg | 20 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-EC2BCB | BPC-157 | 1111-0917 | 99.946% | 111.4%11.14 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-DCE6AE | Selank | 1111-0923 | 99.944% | 111.4%11.14 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CE3971 | Glutathione | 1111-0929 | 99.922% | 109.9%1648.83 of 1500 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CDB4FE | PT-141 | 1111-0915 | 99.979% | 109.1%10.91 of 10 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CBF9AA | 5-Amino-1MQ | 1111-0930 | 99.948% | 112.8%5.64 of 5 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CA4B01 | Kisspeptin-10 | 1111-0925 | 99.966% | 118.9%11.89 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B88FC4 | Thymosin alpha-1 | 1111-0937 | 99.968% | 105.2%5.26 of 5 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A1C619 | GHK-Cu | 111-0922 | 99.944% | 105.4%105.39 of 100 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A02FBB | AOD-9604 | 1111-0921 | 99.973% | 114.2%5.71 of 5 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A011AA | SS-31 | 1111-0919 | 99.972% | 118.1%11.81 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9977B9 | NAD+ | 1111-0934 | 99.929% | 107.9%539.62 of 500 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-832ADF | ARA-290 | 1111-0932 | 99.933% | 118.8%11.88 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7C245E | Epithalon | 1111-0916 | 99.933% | 112.7%56.36 of 50 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7624CB | MOTS-c | 1111-0926 | 99.933% | 105.6%10.56 of 10 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-56B2EA | CJC-1295 no DAC | 1111-0920 | 99.981% | 111.1%11.11 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4D0E4B | LL-37 | 1111-0927 | 99.964% | 111.2%5.56 of 5 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-45C312 | SLU-PP-332 | 1111-0935 | 99.986% | 116.2%5.81 of 5 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-36C612 | Semax | 1111-0924 | 99.977% | 112.6%11.26 of 10 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1B9420 | DSIP | 1111-0936 | 99.952% | 108.8%16.32 of 15 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1A61CA | TB-500 (Thymosin B4) | 1111-0918 | 99.971% | 108.2%10.82 of 10 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-187FBB | Ipamorelin | 1111-0933 | 99.981% | 109.7%10.97 of 10 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-130212 | KPV | 111-0938 | 99.987% | 106.2%10.62 of 10 mg | 29 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-02F932 | Retatrutide | 1111-0928 | 99.958% | 111.5%22.29 of 20 mg | 29 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |